Hungary, July 3 -- Hungary based Astrazeneca Kft. has secured contract from Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie for Pharmaceutical products - Delivery of medicinal products containing the substances Acalabrutinibum, Ravulizumabum and Trastuzumabum derutecan financed under Drug Programs . The value of the contract is worth 238000.03 HUF .
Published by HT Digital Content Services with permission from Pivotal Sources....